Oregon Health Authority Doubles Key Fees, Reshapes Psilocybin Program Rules

Oregon's Health Authority (OHA) is proposing significant regulatory changes to its psilocybin-assisted therapy program, including doubling key service fees and eliminating reduced-cost options. These modifications aim to restructure the program's financial framework while maintaining accessibility for patients seeking psilocybin therapy for mental health conditions. The proposed changes are currently subject to public comment and debate, with stakeholders expressing varied perspectives on affordability and program sustainability. Psilocybin therapy has shown clinical promise for treatment-resistant depression, anxiety, and PTSD in supervised settings. The regulatory shifts reflect ongoing efforts to balance program costs with equitable access to emerging psychedelic-assisted treatments.